Evidence map›Paper›PMID 29438363›Full record

ArticleBritish journal of cancer2018

CD9-positive exosomes from cancer-associated fibroblasts stimulate the migration ability of scirrhous-type gastric cancer cells.

Yuichiro Miki, Masakazu Yashiro, Tomohisa Okuno, Kishu Kitayama, Go Masuda, Kosei Hirakawa, Masaichi Ohira

Abstract read
In one paragraph

Article in British journal of cancer, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 57 papers.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

57 citing papers in PubMed.

  1. Review
  2. CD133Current cancer drug targets · 2026
    Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Functions and Clinical Applications of Exosomes in Gastric Cancer.International journal of biological sciences · 2025
    Review
  11. Article
  12. Review
  13. Review
  14. Review
  15. The biological role of extracellular vesicles in gastric cancer metastasis.Frontiers in cell and developmental biology · 2024
    Review
  16. Review
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yuichiro MikiDepartment of Surgical Oncology, Osaka City University Graduate School of Medicine, Osaka 545-8585, Japan.
Masakazu YashiroDepartment of Surgical Oncology, Osaka City University Graduate School of Medicine, Osaka 545-8585, Japan.
Tomohisa OkunoDepartment of Surgical Oncology, Osaka City University Graduate School of Medicine, Osaka 545-8585, Japan.
Kishu KitayamaDepartment of Surgical Oncology, Osaka City University Graduate School of Medicine, Osaka 545-8585, Japan.
Go MasudaDepartment of Surgical Oncology, Osaka City University Graduate School of Medicine, Osaka 545-8585, Japan.
Kosei HirakawaDepartment of Surgical Oncology, Osaka City University Graduate School of Medicine, Osaka 545-8585, Japan.
Masaichi OhiraDepartment of Surgical Oncology, Osaka City University Graduate School of Medicine, Osaka 545-8585, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This corrects the article DOI: 10.1038/bjc.2017.85.

Indexed as

Adenocarcinoma, ScirrhousCancer-Associated FibroblastsCell CommunicationCell Line, TumorCell MovementExosomesFemaleHumansNeoplasm InvasivenessStomach NeoplasmsTetraspanin 28Tetraspanin 29Tetraspanin 30CD63 protein, humanCD81 protein, humanCD9 protein, humanTetraspanin 28Tetraspanin 29Tetraspanin 30

Identifiers

PMID29438363
PMCPMC5886122

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.